Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors

Bibliography

• Ferrini MG, Davila HH, Kovanecz I, Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006;20:429-35
   Google Scholar
• Gori T, Sicuro S, Dragoni S, Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study. Circulation 2005;111:742-6
   PubMed Web of Science ®Google Scholar
• Hatzimouratidis K, Hatzichristou D. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 2007;51:75-89
   PubMed Web of Science ®Google Scholar
• Sirad F, Hlaing S, Kovanecz I, Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat. J Sex Med 2011;8(4):1048-60
   PubMed Web of Science ®Google Scholar
• Leungwattanakij S, Bivalacqua TJ, Usta MF, Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003;24(2):239-45
   PubMed Web of Science ®Google Scholar
• Diegelmann RF. Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol 1997;157:298-302
   PubMed Web of Science ®Google Scholar
• McCullough A. Penile change following radical prostatectomy: size, smooth muscle atrophy, and curve. Curr Urol Rep 2008;9(6):492-9
   PubMedGoogle Scholar
• Ferrini MG, Kovanecz I, Sanchez S, Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med 2009;6(2):415
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Morelli A, Filippi S, Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res 2008;20:60-7
   PubMed Web of Science ®Google Scholar
• Ferrini MG, Rivera S, Moon J, The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes. J Sex Med 2010;7:3033-44
   PubMed Web of Science ®Google Scholar
• Hotta Y, Hattori M, Kataoka T, Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction. J Sex Med 2011;8:705-11
   PubMed Web of Science ®Google Scholar
• Lee CH, Shin JH, Ahn GJ, Udenafil enhances the recovery of erectile function and ameliorates the pathophysiological consequences of cavernous nerve resection. J Sex Med 2010;7(7):2564-71
   PubMed Web of Science ®Google Scholar
• Kim H, Sohn DW, Kim SD, The effect of mirodenafil on the penile erection and corpus cavernosum in the rat model of cavernosal nerve injury. Int J Impot Res 2010;22(5):291-7
   PubMed Web of Science ®Google Scholar
• Aversa A, Caprio M, Antelmi A, Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro. J Sex Med 2011;8:696-704
   PubMed Web of Science ®Google Scholar
• Tomada N, Tomada I, Cruz F, Characterization of VEGF and angiopoietins expression in human corpus cavernosum during aging. J Sex Med 2010;7(4 Pt 1):1410-18
   PubMed Web of Science ®Google Scholar
• Liu G, Sun X, Dai Y, Chronic administration of sildenafil modified the impaired VEGF system and improved the erectile function in rats with diabetic erectile dysfunction. J Sex Med 2010;7:3868-78
   PubMed Web of Science ®Google Scholar
• Song YS, Lee HJ, Park IH, Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res 2007;19:378-85
   PubMed Web of Science ®Google Scholar
• Han G, Tar M, Kuppam DS, Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med 2010;7(1 Pt 1):224-33
   PubMed Web of Science ®Google Scholar
• Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical prostatectomy. J Urol 2004;171:771-4
   PubMed Web of Science ®Google Scholar
• Padma-Nathan H, McCullough AR, Levine LA, Study Group. Randomized, double-blind, placebo-controlled study of post-operative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve sparing radical prostatectomy. Int J Impot Res 2008;20:479-86
   PubMed Web of Science ®Google Scholar
• Montorsi F, Brock G, Lee J, Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54(4):924-31
   PubMed Web of Science ®Google Scholar
• McCullough AR, Hellstrom WG, Wang R, Recovery of erectile function after nerve sparing radical prostatectomy and penile rehabilitation with nightly intraurethral alprostadil versus sildenafil citrate. J Urol 2010;183(6):2451-6
   PubMed Web of Science ®Google Scholar
• Mosbah A, El Bahnasawy M, Osman Y, Early versus late rehabilitation of erectile function after nerve-sparing radical cystoprostatectomy: a prospective randomized study. J Sex Med 2010; [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Rambhatla A, Kovanecz I, Ferrini M, Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review. Int J Impot Res 2008;20(1):30-4
   PubMed Web of Science ®Google Scholar
• Magheli A, Burnett AL. Medscape. Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol 2009;6(8):415-27
   PubMed Web of Science ®Google Scholar
• Shindel AW. 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME). J Sex Med 2009;6(7):1794-808; quiz 1793, 1809-10
   PubMed Web of Science ®Google Scholar
• Hatzimouratidis K, Burnett AL, Hatzichristou D, Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol 2009;55(2):334-47
   PubMed Web of Science ®Google Scholar
• Briganti A, Gallina A, Salonia A, The case for postoperative PDE-5 inhibitor drug treatment after radical prostatectomy. J Endourol 2008;22(9):2025-7
   PubMed Web of Science ®Google Scholar
• El-Sakka AI, Yassin AA. Amelioration of penile fibrosis: myth or reality. J Androl 2010;31:324-35
   PubMed Web of Science ®Google Scholar
• El-Sakka AI. Reversion of penile fibrosis: current information and new horizon. Arab J Urol 2011; In press; doi:10.1016/j.aju.2011.03.013.
   Google Scholar